新生儿缺血缺氧性脑病辅助检查和治疗手段的研究进展  

The Research Progress Of The Auxiliary Examination And Treatment Of Neonatal Hypoxic-ischemic Encephalopathy

作　　者：刘晓欢 呼格吉乐[2] 高乃康[2] 兰海霞[3] LIU Xiao-huan;HUGEjile;GAO Nai-kang;LAN Hai-xia(Inner Mengolia Medical University,Hohhot 010059 China;The Affiliated Hospital of Inner Mongolia Medical University,clinical laboratory and neurosurgery,Hohhot 010050 China;The 253th Hospital of PLA,paediatrics,Hohhot 010000 China)

机构地区：[1]内蒙古医科大学 [2]内蒙古医科大学附属医院检验科神经外科,内蒙古呼和浩特010050 [3]解放军第253医院儿科,内蒙古呼和浩特010000

出　　处：《内蒙古医学杂志》2018年第7期788-790,共3页Inner Mongolia Medical Journal

基　　金：内蒙古自然科学基金资助项目(2017MS0835);内蒙古自治区科技计划项目(2017)

摘　　要：新生儿缺血缺氧性脑病(HIE)是指围生期窒息引起的部分或完全缺氧、脑血流减少或暂停而导致胎儿或新生儿脑损伤。早期诊断和早期干预治疗是降低HIE死亡率和致残率的重要手段。本文就缺血缺氧性脑病的血清学NSE、S100B、MBP、TNF-α的检查、DWI(磁共振加权成像)、EPO和脑苷肌肽等治疗手段的新进展进行简要综述。Neonatal hypoxic-ischemic encephalopathy（HIE）is the partial or complete hypoxia and cerebral blood flow reduction or suspension caused by the pericardial asphyxia,resulting in fetal or neonatal brain injury.Early diagnosis and early intervention are important to reduce HIE mortality and morbidity.In this paper,we briefly reviewed the new advances in the treatment of hypoxic ischemic encephalopathy（NSE）,S100 B,MBP,TNF-α,weighted imaging（MRI）DWI,EPO,and cerebroside peptide.

关 键 词：新生儿缺血缺氧性脑病 S100B DWI 脑苷肌肽 

分 类 号：R722.1[医药卫生—儿科]